3249 |
Valve-in-Valve |
Darren L. Walters |
Apr. 25. 17 |
3248 |
Technical Lessons for TAVR; Expert Experience |
Alan C. Yeung |
Apr. 25. 17 |
3247 |
DECISION-CTO Trial: Treat or Not Treat CTO |
Seung-Whan Lee |
Apr. 25. 17 |
3246 |
Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC |
Jung-Min Ahn |
Apr. 25. 17 |
3245 |
How To Manage Grey Zone FFR?: Data from IRIS FFR Registry |
Seung-Jung Park |
Apr. 25. 17 |
3244 |
Asan-MV Registry: Confusing MI Definition in Studies Comparing PCI and CABG |
Min Soo Cho |
Apr. 25. 17 |
3243 |
EMERALD Study: Exploring the MEchanism of the Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and ComputationaL Fluid Dynamics |
Bon-Kwon Koo |
Apr. 25. 17 |
3242 |
ILLUMEN-3 and Others: Imaging-Guided PCI Optimization |
Akiko Maehara |
Apr. 25. 17 |
3241 |
[Web-based Lecture] ABSORB-II: BRS Safety Concerns or Still Promising |
Stephen G. Ellis |
Apr. 25. 17 |
3240 |
Updated DES Trials: Contemporary and Future Devices |
Adnan Kastrati |
Apr. 25. 17 |